# 01 - SECTION 1 Neoplastic Disorders

## SECTION 1 Neoplastic Disorders

Section 1	 Neoplastic Disorders
Dan L. Longo

Approach to the Patient 

with Cancer
The application of current treatment techniques (surgery, radiation 
therapy, chemotherapy, and biologic therapy) results in the cure of 
nearly two of three patients diagnosed with cancer. Nevertheless, 
patients experience the diagnosis of cancer as one of the most trau­
matic and revolutionary events that has ever happened to them. Inde­
pendent of prognosis, the diagnosis brings with it a change in a person’s 
self-image and in their role in the home and workplace. The prognosis 
of a person who has just been found to have pancreatic cancer is the 
same as the prognosis of the person with aortic stenosis who develops 
the first symptoms of congestive heart failure (median survival, 
~8 months). However, the patient with heart disease may remain 
functional and maintain a self-image as a fully intact person with just 
a malfunctioning part, a diseased organ (“a bum ticker”). By contrast, 
the patient with pancreatic cancer has a completely altered self-image 
and is viewed differently by family and anyone who knows the 
diagnosis. The patient is being attacked and invaded by a disease 
that could be anywhere in the body. Every ache or pain takes on 
TABLE 73-1  Distribution of Cancer Incidence and Deaths for 2021
MALE
FEMALE
SITES
%
NUMBER
SITES
%
NUMBER
Cancer Incidence
Prostate

299,010
Breast

310,720
Lung

116,310
Lung

118,270
Colorectal

81,540
Colorectal

71,270
Bladder

63,070
Endometrial

67,880
Melanoma

59,170
Melanoma

41,470
Kidney

52,380
Lymphoma

36,030
Lymphoma

44,590
Pancreas

31,910
Oral cavity

41,510
Thyroid

31,520
Leukemia

36,450
Kidney

29,230
Pancreas

34,530
Leukemia

26,320
All others

200,520
All others

207,440
All sites

1,029,080
All sites

972,060
Cancer Deaths
Lung

65,790
Lung

59,280
Prostate

35,250
Breast

42,250
Colorectal

28,700
Pancreas

24,480
Pancreas

25,270
Colorectal

24,310
Liver

19,120
Endometrial

13.250
Leukemia

13,640
Ovary

12,740
Esophagus

12,880
Liver

10,720
Bladder

12,290
Leukemia

10,030
Lymphoma

11,780
Lymphoma

8,360
CNS

10,690
CNS

8,070
All others

87,390
All others

75,4330
All sites

322,800
All sites

288,920
Source: From RL Siegel et al: Cancer statistics, 2024. CA Cancer J Clin 74:12, 2024. Reproduced John Wiley & Sons Ltd.

Oncology and Hematology
PART 4
desperate significance. Cancer is an exception to the coordinated 
interaction among cells and organs. In general, the cells of a multicel­
lular organism are programmed for collaboration. Many diseases occur 
because the specialized cells fail to perform their assigned task. Cancer 
takes this malfunction one step further. Not only is there a failure of the 
cancer cell to maintain its specialized function, but it also strikes out 
on its own; the cancer cell competes to survive using natural mutability 
and natural selection to seek advantage over normal cells in a reca­
pitulation of evolution. One consequence of the traitorous behavior of 
cancer cells is that the patient feels betrayed by their body. The cancer 
patient feels that they, and not just a body part, are diseased.
THE MAGNITUDE OF THE PROBLEM
No nationwide cancer registry exists; therefore, the incidence of cancer 
is estimated on the basis of the National Cancer Institute’s Surveillance, 
Epidemiology, and End Results (SEER) database, which tabulates 
cancer incidence and death figures from 13 sites, accounting for about 
10% of the U.S. population, and from population data from the U.S. 
Census Bureau. In 2024, 2.001 million new cases of invasive cancer 
(1,029,080 men and 927,060 women) were diagnosed, and 611,720 per­
sons (322,800 men and 288,920 women) died from cancer. The percent 
distribution of new cancer cases and cancer deaths by site for men and 
women is shown in Table 73-1. Cancer mortality continues to decline; 
however, 6 of the 10 most common cancers have increased in incidence 
by 1–3% in recent years, and troubling disparities among different 
racial/ethnic groups persist. Mortality is twice as high in black people 
than white people for cancers of the prostate, stomach, and uterine 
corpus. Cancer is the cause of one in four deaths in the United States.